EYEN / Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q2 2022 Results - Earnings Call Transcript

Eyenovia has obtained the first required state pharmacy license from New York, allowing them to obtain the first commercial sale of their drug candida more_horizontal

Eyenovia, Inc. (NASDAQ:EYEN ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Eric Ribner - Investor Relations Michae more_horizontal

I will update for my readers on the background of Eyenovia. I will give the readers an explanation of the need for their business model and the advant more_horizontal

Eyenovia, Inc. (NASDAQ:EYEN ) Q4 2022 Results Conference Call March 30, 2023 4:30 PM ET Company Participants Eric Ribner - IR Michael Rowe - CEO John more_horizontal

I will update my previous two articles about Eyenovia. NDA accepted with no outside advisory committee formed to review their submission. more_horizontal

I will update the history I've had with Eyenovia. I will share with the reader the interim and pending events since my previous article. more_horizontal

Eyenovia, Inc. (NASDAQ:EYEN ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Eric Ribner - Investor Relations Mich more_horizontal

Eyenovia, Inc. (NASDAQ:EYEN ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Eric Ribner - Investor Relations Sean I more_horizontal